HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

eculizumab

binds terminal complement protein C5
Also Known As:
5G1.1; Alexion; Elizaria; H5G1-1; H5G1.1; H5G1.1VHC+H5G1.1VLC; H5G11; Soliris
Networked: 1337 relevant articles (232 outcomes, 144 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Risitano, Antonio M: 27 articles (06/2022 - 09/2006)
2. Hill, Anita: 27 articles (03/2022 - 10/2005)
3. Hillmen, Peter: 26 articles (09/2022 - 02/2004)
4. Brodsky, Robert A: 26 articles (11/2021 - 09/2006)
5. Schrezenmeier, Hubert: 23 articles (09/2022 - 09/2006)
6. Röth, Alexander: 21 articles (05/2021 - 09/2006)
7. Frémeaux-Bacchi, Véronique: 20 articles (01/2022 - 04/2011)
8. Licht, Christoph: 17 articles (08/2020 - 09/2007)
9. Fakhouri, Fadi: 16 articles (01/2022 - 12/2012)
10. van de Kar, Nicole C A J: 15 articles (03/2022 - 07/2012)

Related Diseases

1. Atypical Hemolytic Uremic Syndrome
2. Hemolysis
3. Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
4. Thrombotic Microangiopathies
5. Myasthenia Gravis

Related Drugs and Biologics

1. Complement System Proteins (Complement)
2. Monoclonal Antibodies
3. Complement Inactivating Agents
4. ravulizumab
5. Rituximab (Mabthera)
6. Complement C5 (Complement 5)
7. Cholinergic Receptors
8. glucose-mannose-glucose
9. Intravenous Immunoglobulins (IVIG)
10. Antibodies

Related Therapies and Procedures

1. Therapeutics
2. Plasma Exchange
3. Kidney Transplantation
4. Activities of Daily Living (ADL)
5. Duration of Therapy